Cataplexy and monoamine oxidase deficiency in Norrie disease
暂无分享,去创建一个
[1] E. Mignot,et al. Effect of 5-HT1A receptor agonists and antagonists on canine cataplexy. , 1995, The Journal of pharmacology and experimental therapeutics.
[2] Clarke Kh. Strategies for increasing nursing involvement in facility planning. , 1995 .
[3] D. Vossler. Nonepileptic seizures of physiologic origin , 1995 .
[4] K. Werdan,et al. Bidirectional effects of endogenous opioid peptides on endothelin release rates in porcine aortic endothelial cell culture: mediation by delta opioid receptor and opioid receptor antagonist-insensitive mechanisms. , 1995, The Journal of pharmacology and experimental therapeutics.
[5] E. Mignot,et al. Neuropharmacology and neurochemistry of canine narcolepsy. , 1994, Sleep.
[6] Xini Zhang,et al. Effects of Gestational Exposure to Monoamine Oxidase Inhibitors in Rats: Preliminary Behavioral and Neurochemical Studies , 1994, Neuropsychopharmacology.
[7] Borrie Wd. Progress in Australian demography. , 1994 .
[8] M. Goldberg,et al. Identification of a nonsense mutation at codon 128 of the Norrie's disease gene in a male infant. , 1993, Archives of ophthalmology.
[9] C. Guilleminault,et al. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy. , 1993, The Journal of pharmacology and experimental therapeutics.
[10] P. N. Rao,et al. Inversion (X)(p11.4q22) associated with Norrie disease in a four generation family. , 1993, American journal of medical genetics.
[11] J. Montplaisir,et al. Effects of modafinil on symptomatology of human narcolepsy. , 1993, Clinical neuropharmacology.
[12] M. Aldrich,et al. Autoradiographic studies of post-mortem human narcoleptic brain , 1993, Neurophysiologie Clinique/Clinical Neurophysiology.
[13] E. Richelson,et al. Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8] neurotensin(8-13). , 1993, The Journal of pharmacology and experimental therapeutics.
[14] B. Hirsch,et al. Pericentric inversion of chromosome 4 giving rise to dup(4p) and dup(4q) recombinants within a single kindred. , 1993, American journal of medical genetics.
[15] R. Cantor,et al. Linkage analysis of Norrie disease with an X-chromosomal ornithine aminotransferase locus. , 1993, Transactions of the American Ophthalmological Society.
[16] M. Haasemann,et al. Norrie disease is caused by mutations in an extracellular protein resembling C–terminal globular domain of mucins , 1992, Nature Genetics.
[17] M. Jobling,et al. Isolation and characterization of a candidate gene for Norrie disease , 1992, Nature Genetics.
[18] S. Kish,et al. Brain neurotransmitter changes in human narcolepsy , 1992, Neurology.
[19] D. Murphy,et al. Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. , 1992, American journal of medical genetics.
[20] M. Ludman,et al. GMS syndrome: a new dominant condition with goniodysgenesis, mental retardation, and short stature. , 1992, American journal of medical genetics.
[21] D. Murphy,et al. Abnormal protein in the cerebrospinal fluid of patients with a submicroscopic X-chromosomal deletion associated with Norrie disease: preliminary report. , 1991, Applied and theoretical electrophoresis : the official journal of the International Electrophoresis Society.
[22] A. Chapelle,et al. Monoamine oxidase deficiency in males with an X chromosome deletion , 1989, Neuron.
[23] C. Maggs. Ethel Manson and Henry Burdett: two great minds not thinking alike. , 1989, History of nursing bulletin.
[24] S. Sheps,et al. Diagnostic evaluation of pheochromocytoma. , 1988, Endocrinology and metabolism clinics of North America.
[25] A. Reiss,et al. Determination of a reference range for whole blood serotonin in a pediatric population using high pressure liquid chromatography with electrochemical detection. , 1986, Clinical biochemistry.
[26] G. Sweeney,et al. Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases. , 1986, Clinical biochemistry.
[27] D. Murphy,et al. Platelet and plasma amine oxidase activity in 680 normals: Sex and age differences and stability over time , 1976 .
[28] W. Ganado. The narcolepsy syndrome. , 1958, Neurology.